Paper9546285
Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL.
Cobbers JM and 14 others. Brain Pathol, 1998. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL. Papers, record 9546285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9546285
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Central Nervous System Neoplasms | Major topic |
| Cyclin-Dependent Kinase Inhibitor p16 | Major topic |
| Gene Expression Regulation | Major topic |
| Lymphoma, B-Cell | Major topic |
| Lymphoma, T-Cell | Major topic |
| Mutation | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Aged | |
| Female | |
| Humans | |
| Immunohistochemistry | |
| Male | |
| Middle Aged | |
| Molecular Biology |
Source PubMed
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1375111 | Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. | Blood | 1992 | https://conductscience.org/library/papers/1375111 | PubMed |
| 2 | 7815080 | Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue. | J Neuropathol Exp Neurol | 1995 | https://conductscience.org/library/papers/7815080 | PubMed |
| 3 | 8620534 | Role of the INK4a locus in tumor suppression and cell mortality. | Cell | 1996 | https://conductscience.org/library/papers/8620534 | PubMed |
| 4 | 8965097 | Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. | J Neuropathol Exp Neurol | 1996 | https://conductscience.org/library/papers/8965097 | PubMed |
| 5 | 9600204 | Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas. | J Neuropathol Exp Neurol | 1998 | https://conductscience.org/library/papers/9600204 | PubMed |
| 6 | 8939849 | Cancer cell cycles. | Science | 1996 | https://conductscience.org/library/papers/8939849 | PubMed |
| 7 | 8289506 | Altered expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas. | Leukemia | 1994 | https://conductscience.org/library/papers/8289506 | PubMed |
| 8 | 1466395 | Identification of monoclonal B-cell populations by rapid cycle polymerase chain reaction. A practical screening method for the detection of immunoglobulin gene rearrangements. | Am J Pathol | 1992 | https://conductscience.org/library/papers/1466395 | PubMed |
| 9 | 9000591 | Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9000591 | PubMed |
| 10 | 7632963 | Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. | Blood | 1995 | https://conductscience.org/library/papers/7632963 | PubMed |
| 11 | 8068936 | A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. | Blood | 1994 | https://conductscience.org/library/papers/8068936 | PubMed |
| 12 | 3039510 | Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3039510 | PubMed |
| 13 | 8259215 | A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. | Nature | 1993 | https://conductscience.org/library/papers/8259215 | PubMed |
| 14 | 8044775 | Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. | Cancer Res | 1994 | https://conductscience.org/library/papers/8044775 | PubMed |
| 15 | 7536040 | Transcriptional regulation of the mts1 gene in human lymphoma cells: the role of DNA-methylation. | Biochim Biophys Acta | 1995 | https://conductscience.org/library/papers/7536040 | PubMed |
| 16 | 8523072 | Primary central nervous system lymphomas--new pathological developments. | J Neurooncol | 1995 | https://conductscience.org/library/papers/8523072 | PubMed |
| 17 | 8705788 | Primary non-Hodgkin lymphomas of the CNS-proliferation, oncoproteins and Epstein-Barr-virus. | Gen Diagn Pathol | 1996 | https://conductscience.org/library/papers/8705788 | PubMed |
| 18 | 7987821 | CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. | Cancer Res | 1994 | https://conductscience.org/library/papers/7987821 | PubMed |
| 19 | 8751137 | Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins. | J Mol Med (Berl) | 1995 | https://conductscience.org/library/papers/8751137 | PubMed |
| 20 | 6961453 | Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6961453 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41008837 | The EBV-Positive Tumor Methylome Is Distinct from EBV-Negative in Diffuse Large B-Cell Lymphoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41008837 | PubMed |
| 38730692 | The Molecular Landscape of Primary CNS Lymphomas (PCNSLs) in Children and Young Adults. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38730692 | PubMed |
| 38598668 | Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review. | Neuro Oncol | 2024 | https://conductscience.org/library/papers/38598668 | PubMed |
| 37322012 | Primary central nervous system lymphoma. | Nat Rev Dis Primers | 2023 | https://conductscience.org/library/papers/37322012 | PubMed |
| 37190213 | Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37190213 | PubMed |
| 34944954 | Impact of a Faulty Germinal Center Reaction on the Pathogenesis of Primary Diffuse Large B Cell Lymphoma of the Central Nervous System. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34944954 | PubMed |
| 34283060 | Molecular Update and Evolving Classification of Large B-Cell Lymphoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34283060 | PubMed |
| 31109360 | Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma. | Diagn Pathol | 2019 | https://conductscience.org/library/papers/31109360 | PubMed |
| 30617197 | Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Blood | 2019 | https://conductscience.org/library/papers/30617197 | PubMed |
| 30423172 | Introduction of novel agents in the treatment of primary CNS lymphoma. | Neuro Oncol | 2019 | https://conductscience.org/library/papers/30423172 | PubMed |
| 27101868 | TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy. | Acta Neuropathol Commun | 2016 | https://conductscience.org/library/papers/27101868 | PubMed |
| 24578887 | Significance of CDKN2A gene A148T variant in patients with bladder cancer. | Cent European J Urol | 2011 | https://conductscience.org/library/papers/24578887 | PubMed |
| 21818113 | Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. | Leukemia | 2011 | https://conductscience.org/library/papers/21818113 | PubMed |
| 21803762 | Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas. | Neuro Oncol | 2011 | https://conductscience.org/library/papers/21803762 | PubMed |
| 20025734 | Array-based DNA methylation profiling of primary lymphomas of the central nervous system. | BMC Cancer | 2009 | https://conductscience.org/library/papers/20025734 | PubMed |
| 19560747 | Biology and treatment of primary central nervous system lymphoma. | Neurotherapeutics | 2009 | https://conductscience.org/library/papers/19560747 | PubMed |
| 15481438 | Epigenetic inactivation of tumor suppressor genes in hematologic malignancies. | Int J Hematol | 2004 | https://conductscience.org/library/papers/15481438 | PubMed |
| 12937144 | Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. | Am J Pathol | 2003 | https://conductscience.org/library/papers/12937144 | PubMed |
| 12802586 | Analysis of chromosomal copy number changes and oncoprotein expression in primary central nervous system lymphomas: frequent loss of chromosome arm 6q. | Virchows Arch | 2003 | https://conductscience.org/library/papers/12802586 | PubMed |
| 11804283 | Homozygous deletion of INK4a/ARF genes and overexpression of bcl-2 in relation with poor prognosis in immunocompetent patients with primary central nervous system lymphoma of the diffuse large B-cell type. | J Neurooncol | 2001 | https://conductscience.org/library/papers/11804283 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| CCND1 | 595 | PubTator's text mining | https://conductscience.org/library/genes/595 | NCBI Gene |
| CDK4 | 1019 | PubTator's text mining | https://conductscience.org/library/genes/1019 | NCBI Gene |
| CDKN1A | 1026 | PubTator's text mining | https://conductscience.org/library/genes/1026 | NCBI Gene |
| CDKN2A | 1029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| MDM2 | 4193 | PubTator's text mining | https://conductscience.org/library/genes/4193 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| RB1 | 5925 | PubTator's text mining | https://conductscience.org/library/genes/5925 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9546285
GET https://conductscience.org/api/papers/v1/9546285/references?page=2